Literature DB >> 24592973

Evaluation of fluorescence in-situ hybridization in monomorphic endometrial stromal neoplasms and their histological mimics: a review of 49 cases.

Colin J R Stewart1, Yee C Leung, Ashleigh Murch, Joanne Peverall.   

Abstract

AIMS: To perform a population-based review of monomorphic endometrial stromal tumours and their histological mimics presenting over a 20-year period, including an evaluation of fluorescence in-situ hybridization (FISH) for the JAZF1 and YWHAE breakaparts. METHODS AND
RESULTS: Forty-nine tumours were examined, comprising 13 histological mimics and 36 endometrial stromal tumours [six stromal nodules (ESNs), 25 low-grade stromal sarcomas (ESSs), and five monomorphic undifferentiated sarcomas (mUESs)]. Nine ESSs showed variant histological patterns, including smooth muscle, sex cord-like/glandular, fibrous or rhabdoid differentiation. Three ESSs were initially misclassified as benign uterine lesions, and, conversely, three benign mimics were originally reported as ESSs. One mUES showed a prominent pseudopapillary pattern. Fluorescence in-situ hybridization demonstrated JAZF1 breakaparts in five of six ESNs and 16 of 25 ESSs; however, only three of nine ESS variants were positive. YWHAE breakaparts were present in four of five mUESs. Analysis of a subsequent metastasis in the YWHAE breakapart-negative mUES demonstrated a YWHAE deletion. None of the histological mimics was positive in FISH analysis. Diffuse cyclin D1 expression was restricted to mUESs in this series.
CONCLUSIONS: Endometrial stromal neoplasms continue to present diagnostic difficulty. Fluorescence in-situ hybridization analysis is helpful in distinguishing stromal tumours from their histological mimics and in distinguishing ESS from mUES.
© 2014 John Wiley & Sons Ltd.

Entities:  

Keywords:  JAZF1; YWHAE; endometrial stromal tumour; fluorescence in-situ hybridization; immunohistochemistry; sarcoma

Mesh:

Substances:

Year:  2014        PMID: 24592973     DOI: 10.1111/his.12406

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  9 in total

1.  Novel High-grade Endometrial Stromal Sarcoma: A Morphologic Mimicker of Myxoid Leiomyosarcoma.

Authors:  Lien N Hoang; Amandeep Aneja; Niamh Conlon; Deborah F Delair; Sumit Middha; Ryma Benayed; Martee L Hensley; Kay J Park; Travis J Hollmann; Meera R Hameed; Cristina R Antonescu; Robert A Soslow; Sarah Chiang
Journal:  Am J Surg Pathol       Date:  2017-01       Impact factor: 6.394

2.  BCOR is a robust diagnostic immunohistochemical marker of genetically diverse high-grade endometrial stromal sarcoma, including tumors exhibiting variant morphology.

Authors:  Sarah Chiang; Cheng-Han Lee; Colin J R Stewart; Esther Oliva; Lien N Hoang; Rola H Ali; Martee L Hensley; Javier A Arias-Stella; Denise Frosina; Achim A Jungbluth; Ryma Benayed; Marc Ladanyi; Meera Hameed; Lu Wang; Yu-Chien Kao; Cristina R Antonescu; Robert A Soslow
Journal:  Mod Pathol       Date:  2017-06-16       Impact factor: 7.842

Review 3.  Recent advances in the histological and molecular classification of endometrial stromal neoplasms.

Authors:  Joana Ferreira; Ana Félix; Jochen K Lennerz; Esther Oliva
Journal:  Virchows Arch       Date:  2018-10-15       Impact factor: 4.064

4.  YWHAE-rearranged high-grade endometrial stromal sarcoma: Two-center case series and response to chemotherapy.

Authors:  Matthew L Hemming; Andrew J Wagner; Marisa R Nucci; Sarah Chiang; Lu Wang; Martee L Hensley; Suzanne George
Journal:  Gynecol Oncol       Date:  2017-04-05       Impact factor: 5.482

5.  Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.

Authors:  Man Kuen Yung; Kwok Wai Lo; Chi Wai Yip; Grace T Y Chung; Carol Y K Tong; Phyllis F Y Cheung; Tan To Cheung; Ronnie T P Poon; Samuel So; Sheung Tat Fan; Siu Tim Cheung
Journal:  BMC Cancer       Date:  2015-04-11       Impact factor: 4.430

6.  Uterine lesions with sex cord-like architectures: a systematic review.

Authors:  Meng Jia; Ping-Li Sun; Hongwen Gao
Journal:  Diagn Pathol       Date:  2019-11-18       Impact factor: 2.644

7.  Endometrial Stromal Nodule: A Rarity and a Pathological Challenge.

Authors:  Camilla Skovvang Borg; Peter Humaidan; Hanne Noer; Huda Galib Majeed
Journal:  Case Rep Obstet Gynecol       Date:  2015-06-28

Review 8.  Molecular pathogenesis and prognostication of "low-grade'' and "high-grade" endometrial stromal sarcoma.

Authors:  Francesca Micci; Sverre Heim; Ioannis Panagopoulos
Journal:  Genes Chromosomes Cancer       Date:  2020-11-10       Impact factor: 5.006

Review 9.  Update on Endometrial Stromal Tumours of the Uterus.

Authors:  Iolia Akaev; Chit Cheng Yeoh; Siavash Rahimi
Journal:  Diagnostics (Basel)       Date:  2021-03-03
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.